PET imaging of brain inflammation during early epileptogenesis in a rat model of temporal lobe epilepsy

EJNMMI Research

Volumn 2, Issue 1, 2012, Pages 1-13

  Dedeurwaerdere, Stefanie ^a,b   Callaghan, Paul D ^b   Pham, Tien ^b   Rahardjo, Gita L ^b   Amhaoul, Halima ^a   Berghofer, Paula ^b   Quinlivan, Mitchell ^b   Mattner, Filomena ^b   Loc'h, Christian ^b   Katsifis, Andrew ^c   Grégoire, Marie Claude ^b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Neuroinflammation; Rat; Status epilepticus; Temporal lobe epilepsy

Indexed keywords

CARRIER PROTEIN; DIAZEPAM; IMIDAZOPYRIDINE-3-ACETAMIDE I 123; KAINIC ACID; PERIPHERAL BENZODIAZEPINE RECEPTOR 111 F 18; PROTEIN OX 42; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; AUTORADIOGRAPHY; BRAIN REGION; CELL ACTIVATION; CELL LOSS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DISTRIBUTION; ENCEPHALITIS; EPILEPTIC STATE; EPILEPTOGENESIS; GENE OVEREXPRESSION; HIPPOCAMPUS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KINETICS; MALE; METABOLITE; MICROGLIA; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SYMPTOMATOLOGY; TEMPORAL LOBE EPILEPSY;

EID: 84871641458     PISSN: None     EISSN: 2191219X     Source Type: Journal    
DOI: 10.1186/2191-219X-2-60     Document Type: Article

References (37)

1. Vezzani A, French J, Bartfai T, Baram TZ: The role of inflammation in epilepsy. Nat Rev Neurol 2011, 7:31-40.
2. Dedeurwaerdere S, Friedmand A, Fabene PF, Mazarati A, Murashima YL, Vezzani A, Baram TZ: Finding a better drug for epilepsy: antiinflammatory targets. Epilepsia 2012, 53(5):1113-1118.
3. Ravizza T, Balosso S, Vezzani A: Inflammation and prevention of epileptogenesis. Neurosci Lett 2011, 497(3):223-230.
4. Dedeurwaerdere S, Jupp B, O'Brien TJ: Positron emission tomography in basic epilepsy research: a view of the epileptic brain. Epilepsia 2007, 48(Suppl 4):56-64.
5. Sauvageau A, Desjardins P, Lozeva V, Rose C, Hazell AS, Bouthillier A, Butterwort RF: Increased expression of "peripheral-type" benzodiazepine receptors in human temporal lobe epilepsy: implications for PET imaging of hippocampal sclerosis. Metab Brain Dis 2002, 17:3-11.
6. Johnson EW, de Lanerolle NC, Kim JH, Sundaresan S, Spencer DD, Mattson RH, Zoghbi SS, Baldwin RM, Hoffer PB, Seibyl JP, Innis RB: "Central" and "peripheral" benzodiazepine receptors: opposite changes in human epileptogenic tissue. Neurology 1992, 42:811-815.
7. Kumlien E, Hilton-Brown P, Spannare B, Gillberg PG: In vitro quantitative autoradiography of [3 H]-L-deprenyl and [3 H]-PK 11195 binding sites in human epileptic hippocampus. Epilepsia 1992, 33:610-617.
8. Hirvonen J, Kreisl WC, Fujita M, Dustin I, Khan O, Appel S, Zhang Y, Morse C, Pike VW, Innis RB, Theodore W: Increased in vivo expression of an inflammatory marker in temporal lobe epilepsy. J Nucl Med 2012, 53(2):234-240.
9. Fookes CJ, Pham TQ, Mattner F, Greguric I, Loc'h C, Liu X, Berghofer P, Shepherd R, Gregoire MC, Katsifis A: Synthesis and biological evaluation of substituted [18 F]imidazo[1, 2-a]pyridines and [18 F]pyrazolo[1, 5-a] pyrimidines for the study of the peripheral benzodiazepine receptor using positron emission tomography. J Med Chem 2008, 51:3700-3712.
10. Van Camp N, Boisgard R, Kuhnast B, Theze B, Viel T, Gregoire MC, Chauveau F, Boutin H, Katsifis A, Dolle F, Tavitian B: In vivo imaging of neuroinflammation: a comparative study between [(18)F]PBR111, [(11)C] CLINME and [(11)C]PK11195 in an acute rodent model. Eur J Nucl Med Mol Imaging 2010, 37:962-972.
11. Vivash L, Tostevin A, Liu DS, Dalic L, Dedeurwaerdere S, Hicks RJ, Williams DA, Myers DE, O'Brien TJ: Changes in hippocampal GABAA/cBZR density during limbic epileptogenesis: relationship to cell loss and mossy fibre sprouting. Neurobiol Dis 2011, 41:227-236.
12. Dedeurwaerdere S, van Raay L, Morris MJ, Reed RC, Hogan RE, O'Brien TJ: Fluctuating and constant valproate administration gives equivalent seizure control in rats with genetic and acquired epilepsy. Seizure 2011, 20:72-79.
13. Racine RJ: Modification of seizure activity by electrical stimulation II. Motor seizure. Electroencephalogr Clin Neurophysiol 1972, 32:281-294.
14. Veenman L, Leschiner S, Spanier I, Weisinger G, Weizman A, Gavish M: PK 11195 attenuates kainic acid-induced seizures and alterations in peripheral-type benzodiazepine receptor (PBR) protein components in the rat brain. J Neurochem 2002, 80:917-927.
15. Veiga S, Azcoitia I, Garcia-Segura LM: Ro5-4864, a peripheral benzodiazepine receptor ligand, reduces reactive gliosis and protects hippocampal hilar neurons from kainic acid excitotoxicity. J Neurosci Res 2005, 80:129-137.
16. Najm I, El-Skaf G, Massicotte G, Vanderklish P, Lynch G, Baudry M: Changes in polyamine levels and spectrin degradation following kainate-induced seizure activity: effect of difluoromethylornithine. Exp Neurol 116, 116:345-354.
17. Katsifis A, Mattner F, Dikic B, Papazian V: Synthesis of substituted [123I] imidazo[1, 2-a]pyridines as potential probes for the study of the peripheral benzodiazepine receptors using SPECT. Radiochim Acta 2000, 88:229-232.
18. Mattner F, Katsifis A, Staykova M, Ballantyne P, Willenborg DO: Evaluation of a radiolabelled peripheral benzodiazepine receptor ligand in the central nervous system inflammation of experimental autoimmune encephalomyelitis: a possible probe for imaging multiple sclerosis. Eur J Nucl Med Mol Imaging 2005, 32:557-563.
19. Bourdier T, Pham TQ, Henderson D, Jackson T, Lam P, Izard M, Katsifis A: Automated radiosynthesis of [(18)F]PBR111 and [(18)F]PBR102 using the Tracerlab FX(FN) and Tracerlab MX(FDG) module for imaging the peripheral benzodiazepine receptor with PET. Appl Radiat Isot 2012, 70(1):176-183.
20. Katsifis A, Loc'h C, Henderson D, Bourdier T, Pham T, Greguric I, Lam P, Callaghan P, Mattner F, Eberl S, Fulham M: A rapid solid-phase extraction method for measurement of non-metabolised peripheral benzodiazepine receptor ligands, [(18)F]PBR102 and [(18)F]PBR111, in rat and primate plasma. Nucl Med Biol 2011, 38:137-148.
21. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates. 6th edition. London: Academic Press; 2007.
22. Thompson MR, Callaghan PD, Hunt GE, Cornish JL, McGregor IS: A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3, 4 methylenedioxymethamphetamine ("ecstasy"). Neuroscience 2007, 146:509-514.
23. Mattner F, Mardon K, Katsifis A: Pharmacological evaluation of [123I]-CLINDE: a radioiodinated imidazopyridine-3-acetamide for the study of peripheral benzodiazepine binding sites (PBBS). Eur J Nucl Med Mol Imaging 2008, 35:779-789.
24. Kemp BJ, Hruska CB, McFarland AR, Lenox MW, Lowe VJ: NEMA NU 2-2007 performance measurements of the Siemens Inveon preclinical small animal PET system. Phys Med Biol 2009, 54:2359-2376.
25. Van Vliet EA, da Costa Araujo S, Redeker S, van Schaik R, Aronica E, Gorter JA: Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain 2007, 130:521-534.
26. Zhang ZG, Zhang L, Tsang W, Soltanian-Zadeh H, Morris D, Zhang R, Goussev A, Powers C, Yeich T, Chopp M: Correlation of VEGF and angiopoietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ischemia. J Cereb Blood Flow Metab 2002, 22:379-392.
27. Nguyen VH, Verdurand M, Dedeurwaerdere S, Wang H, Zahra D, Gregoire MC, Zavitsanou K: Increased brain metabolism after acute administration of the synthetic cannabinoid HU210: a small animal PET imaging study with 18 F-FDG. Brain Res Bull 2012, 87:172-179.
28. Altar CA, Baudry M: Systemic injection of kainic acid: gliosis in olfactory and limbic brain regions quantified with [3 H]PK 11195 binding autoradiography. Exp Neurol 1990, 109:333-341.
29. Vezzani A, Friedman A: Brain inflammation as a biomarker in epilepsy. Biomark Med 2011, 5:607-614.
30. Banati RB, Goerres GW, Myers R, Gunn RN, Turkheimer FE, Kreutzberg GW, Brooks DJ, Jones T, Duncan JS: [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology 1999, 53:2199-2203.
31. Butler T, Ichise M, Teich AF, Gerard E, Osborne J, French J, Devinsky O, Kuzniecky R, Gilliam F, Pervez F, Provenzano F, Goldsmith S, Vallabhajosula S, Stern E, Silbersweig D: Imaging inflammation in a patient with epilepsy due to focal cortical dysplasia. J Neuroimaging 2011, doi:10.1111/j.1552-6569.2010.00572.x.
32. Owen DR, Gunn RN, Rabiner EA, Bennacef I, Fujita M, Kreisl WC, Innis RB, Pike VW, Reynolds R, Matthews PM, Parker CA: Mixed-affinity binding in humans with 18-kDa translocator protein ligands. J Nucl Med 2011, 52:24-32.
33. Owen DR, Yeo AJ, Gunn RN, Song K, Wadsworth G, Lewis A, Rhodes C, Pulford DJ, Bennacef I, Parker CA, StJean PL, Cardon LR, Mooser VE, Matthews PM, Rabiner EA, Rubio JP: An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood Flow Metab 2012, 32:1-5.
34. Tomkins O, Shelef I, Kaizerman I, Eliushin A, Afawi Z, Misk A, Gidon M, Cohen A, Zumsteg D, Friedman A: Blood-brain barrier disruption in post-traumatic epilepsy. J Neurol Neurosurg Psychiatry 2008, 79:774-777.
35. Bottlaender M, Valette H, Delforge J, Saba W, Guenther I, Curet O, George P, Dolle F, Gregoire MC: In vivo quantification of monoamine oxidase A in baboon brain: a PET study using [(11)C]befloxatone and the multiinjection approach. J Cereb Blood Flow Metab 2010, 30:792-800.
36. Delforge J, Syrota A, Bottlaender M, Varastet M, Loc'h C, Bendriem B, Crouzel C, Brouillet E, Maziere M: Modeling analysis of [11C]flumazenil kinetics studied by PET: application to a critical study of the equilibrium approaches. J Cereb Blood Flow Metab 1993, 13:454-468.
37. Reilac A, Lehnert W, Lin J, Meikle SR, Gregoire M-C: Iterative-based partial volume effects correction with wavelet-based regularization for quantitative PET imaging. IEEETrans Med Imaging Conf proc 2011, 3788-3791.